Article
PIK3CA mutations in breast cancer are associated with poor outcome.
Breast cancer research and treatment - 1 Mar 2006
Li Shao Ying, Rong Minna, Grieu Fabienne, Iacopetta Barry
Abstract excerpt
The phosphatidylinositol-3-kinase (PI3K)-AKT signaling pathway is considered to play an important role in tumorigenesis. Frequent somatic mutations in the PI3K subunit p110alpha (PIK3CA) occur in a variety of cancer types. We screened 250 primary human breast tumors for mutations in PIK3CA in order to determine associations with pathological features and with patient outcome. The frequency of PIK3CA mutations in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
